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Note to Readers
This document is excerpted from CDC’s Guidelines for Infection Control in Dental Health-Care 
Settings — 2003. MMWR 2003;52(No. RR-17):1 – 76. Available at: http://www.cdc.gov/mmwr/PDF/
rr/rr5217.pdf.
Reference numbers in parentheses document the supporting scientific evidence and rationale 
for each recommendation as presented in the 2003 Guidelines. 
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Recommendations
Each recommendation is categorized on the basis of existing scientific data, theoretical rationale, and applicability. 
Rankings are based on the system used by CDC and the Healthcare Infection Control Practices Advisory Committee 
(HICPAC) to categorize recommendations: 
Catagories
Category IA Strongly recommended for 
implementation
Strongly supported by well-designed experimental, clinical, or 
epidemiologic studies.
Category IB Strongly recommended for 
implementation
Supported by experimental, clinical, or epidemiologic studies and a 
strong theoretical rationale.
Category IC Required for implementation 
as mandated by federal or 
state regulation or standard
When IC is used, a second rating can be included to provide the 
basis of existing scientific data, theoretical rationale, and applicability. 
Because of state differences, the reader should not assume that the 
absence of a IC implies the absence of state regulations.
Category II Suggested for implementation Supported by suggestive clinical or epidemiologic studies or a 
theoretical rationale.
Unresolved Issue No recommendation Insufficient evidence or no consensus regarding efficacy exists.
I. Personnel Health Elements of an Infection Control Program 
A. General Recommendations 
1. Develop a written health program for dental 
health care personnel (DHCP) that includes 
policies, procedures, and guidelines for 
education and training; immunizations; exposure 
prevention and postexposure management; 
medical conditions, work-related illness, 
and associated work restrictions; contact 
dermatitis and latex hypersensitivity; and 
maintenance of records, data management, 
and confidentiality (IB) (5, 16 – 18, 22). 
2. Establish referral arrangements with qualified 
health care professionals to ensure prompt 
and appropriate provision of preventive 
services, occupationally related medical 
services, and postexposure management with 
medical follow-up (IB, IC) (5, 13, 19, 22). 
B. Education and Training 
1. Provide DHCP 1) on initial employment, 2) when 
new tasks or procedures affect the employee’s 
occupational exposure, and 3) at a minimum, 
annually, with education and training regarding 
occupational exposure to potentially infectious 
agents and infection-control procedures / protocols 
appropriate for and specific to their assigned 
duties (IB, IC) (5,11,13,14,16,19,22). 
2. Provide educational information appropriate in 
content and vocabulary to the educational level, 
literacy, and language of DHCP (IB, IC) (5,13). 
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C. Immunization Programs 
1. Develop a written comprehensive policy regarding 
immunizing DHCP, including a list of all required 
and recommended immunizations (IB) (5,17,18). 
2. Refer DHCP to a prearranged qualified health 
care professional or to their own health-
care professional to receive all appropriate 
immunizations based on the latest 
recommendations as well as their medical history 
and risk for occupational exposure (IB) (5,17). 
D. Exposure Prevention and Postexposure Management 
1. Develop a comprehensive postexposure 
management and medical follow-up program.
a. Include policies and procedures for prompt 
reporting, evaluation, counseling, treatment, 
and medical follow-up of occupational 
exposures (IB, IC) (5,13,14,19). 
b. Establish mechanisms for referral to a 
qualified health care professional for medical 
evaluation and follow-up (IB, IC) (5,13,14,19).
c. Conduct a baseline tuberculin skin test 
(TST), preferably by using a two-step test, 
for all DHCP who might have contact with 
persons with suspected or confirmed 
infectious tuberculosis (TB), regardless of the 
risk classification of the setting (IB) (20). 
E. Medical Conditions, Work-Related Illness, and Work Restrictions 
1. Develop and have readily available to all DHCP 
comprehensive written policies regarding 
work restriction and exclusion that include 
a statement of authority defining who can 
implement such policies (IB) (5,22). 
2. Develop policies for work restriction and exclusion 
that encourage DHCP to seek appropriate 
preventive and curative care and report their 
illnesses, medical conditions, or treatments that 
can render them more susceptible to opportunistic 
infection or exposures; do not penalize DHCP with 
loss of wages, benefits, or job status (IB) (5,22). 
3. Develop policies and procedures for 
evaluation, diagnosis, and management 
of DHCP with suspected or known 
occupational contact dermatitis (IB) (32). 
4. Seek definitive diagnosis by a qualified health 
care professional for any DHCP with suspected 
latex allergy to carefully determine its specific 
etiology and appropriate treatment as well as 
work restrictions and accommodations (IB) (32). 
F. Records Maintenance, Data Management, and Confidentiality 
1. Establish and maintain confidential medical 
records (e.g., immunization records and 
documentation of tests received as a result of 
occupational exposure) for all DHCP (IB, IC) (5,13). 
2. Ensure that the practice complies with 
all applicable federal, state, and local 
laws regarding medical recordkeeping 
and confidentiality (IC) (13,34). 
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II. Preventing Transmission of Bloodborne Pathogens 
A. Hepatitis B Virus (HBV) Vaccination 
1. Offer the HBV vaccination series to all DHCP with 
potential occupational exposure to blood or other 
potentially infectious material (IA, IC) (2,13,14,19). 
2. Always follow U.S. Public Health Service / CDC 
recommendations for hepatitis B 
vaccination, serologic testing, follow-up, 
and booster dosing (IA, IC) (13,14,19). 
3. Test DHCP for anti-HBs 1 – 2 months 
after completion of the 3-dose 
vaccination series (IA, IC) (14,19). 
4. HCP should complete a second 3-dose vaccine 
series or be evaluated to determine if they are 
HBsAg-positive if no antibody response occurs 
to the primary vaccine series (IA, IC) (14,19). 
5. Retest for anti-HBs at the completion of the 
second vaccine series. If no response to the 
second 3-dose series occurs, nonresponders 
should be tested for HBsAg (IC) (14,19). 
6. Counsel nonresponders to vaccination 
who are HBsAg-negative regarding 
their susceptibility to HBV infection and 
precautions to take (IA, IC) (14,19). 
7. Provide employees appropriate education 
regarding the risks of HBV transmission and the 
availability of the vaccine. Employees who decline 
the vaccination should sign a declination form 
to be kept on file with the employer (IC) (13). 
B. Preventing Exposures to Blood and Other Potentially Infectious Material (OPIM) 
1. General recommendations 
a. Use standard precautions (OSHA’s 
bloodborne pathogen standard retains 
the term universal precautions) for all 
patient encounters (IA, IC) (11,13,19,53). 
b. Consider sharp items (e.g., needles, 
scalers, burs, lab knives, and wires) that 
are contaminated with patient blood and 
saliva as potentially infective and establish 
engineering controls and work practices 
to prevent injuries (IB, IC) (6,13,113). 
c. Implement a written, comprehensive 
program designed to minimize and 
manage DHCP exposures to blood and 
body fluids (IB, IC). (13,14,19,97). 
2. Engineering and work-practice controls 
a. Identify, evaluate, and select devices with 
engineered safety features at least annually 
and as they become available on the market 
(e.g., safer anesthetic syringes, blunt suture 
needle, retractable scalpel, or needleless 
IV systems) (IC) (13,97,110 – 112). 
b. Place used disposable syringes and needles, 
scalpel blades, and other sharp items in 
appropriate puncture-resistant containers 
located as close as feasible to the area in which 
the items are used (IA, IC) (2,7,13,19,113,115). 
c. Do not recap used needles by using both hands 
or any other technique that involves directing 
the point of a needle toward any part of the 
body. Do not bend, break, or remove needles 
before disposal (IA, IC) (2,7,8,13,97,113). 
d. Use either a one-handed scoop technique 
or a mechanical device designed for holding 
the needle cap when recapping needles 
(e.g., between multiple injections and 
before removing from a nondisposable 
aspirating syringe) (IA, IC) (2,7,8,13,14,113). 
3. Postexposure management and prophylaxis 
a. Follow CDC recommendations after 
percutaneous, mucous membrane, or nonintact 
skin exposure to blood or other potentially 
infectious material (IA, IC) (13,14,19). 
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III. Hand Hygiene 
A. General Considerations 
1. Perform hand hygiene with either a 
nonantimicrobial or antimicrobial soap and water 
when hands are visibly dirty or contaminated 
with blood or other potentially infectious 
material. If hands are not visibly soiled, an 
alcohol-based hand rub can also be used. Follow 
the manufacturer’s instructions (IA) (123). 
2. Indications for hand hygiene include 
a. when hands are visibly soiled (IA, IC); 
b. after barehanded touching of inanimate 
objects likely to be contaminated by blood, 
saliva, or respiratory secretions (IA, IC); 
c. before and after treating each patient (IB); 
d. before donning gloves (IB); and 
e. immediately after removing gloves (IB, IC) 
(7 – 9,11,13,113,120 – 123,125,126,138). 
3.  For oral surgical procedures, perform surgical hand 
antisepsis before donning sterile surgeon’s gloves. 
Follow the manufacturer’s instructions by using 
either an antimicrobial soap and water, or soap and 
water followed by drying hands and application of 
an alcohol-based surgical hand-scrub product with 
persistent activity (IB) (121 – 123,127 – 133,144,145). 
4.  Store liquid hand-care products in either disposable 
closed containers or closed containers that can 
be washed and dried before refilling. Do not 
add soap or lotion to (i.e., top off ) a partially 
empty dispenser (IA) (9,120,122,149,150). 
B. Special Considerations for Hand Hygiene and Glove Use 
1. Use hand lotions to prevent skin dryness 
associated with handwashing (IA) (153,154). 
2. Consider the compatibility of lotion and antiseptic 
products and the effect of petroleum or other 
oil emollients on the integrity of gloves during 
product selection and glove use (IB) (2,14,122,155). 
3. Keep fingernails short with smooth, filed 
edges to allow thorough cleaning and 
prevent glove tears (II) (122,123,156). 
4. Do not wear artificial fingernails or extenders 
when having direct contact with patients at 
high risk (e.g., those in intensive care units 
or operating rooms) (IA) (123,157 – 160). 
5. Use of artificial fingernails is usually 
not recommended (II) (157 – 160). 
6. Do not wear hand or nail jewelry if it makes 
donning gloves more difficult or compromises the 
fit and integrity of the glove (II) (123,142,143).
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IV. Personal Protective Equipment
A. Masks, Protective Eyewear, and Face Shields
1. Wear a surgical mask and eye protection with 
solid side shields or a face shield to protect 
mucous membranes of the eyes, nose, and 
mouth during procedures likely to generate 
splashing or spattering of blood or other 
body fluids (IB, IC) (1,2,7,8,11,13,137). 
2. Change masks between patients or during patient 
treatment if the mask becomes wet (IB) (2). 
3. Clean with soap and water, or if visibly soiled, 
clean and disinfect reusable facial protective 
equipment (e.g., clinician and patient protective 
eyewear or face shields) between patients (II) (2). 
B. Protective Clothing 
1. Wear protective clothing (e.g., reusable or 
disposable gown, laboratory coat, or uniform) 
that covers personal clothing and skin (e.g., 
forearms) likely to be soiled with blood, 
saliva, or OPIM (IB, IC) (7,8,11,13,137). 
2. Change protective clothing if visibly soiled 
(134); change immediately or as soon as 
feasible if penetrated by blood or other 
potentially infectious fluids (IB, IC) (13). 
3. Remove barrier protection, including gloves, 
mask, eyewear, and gown before departing 
work area (e.g., dental patient care, instrument 
processing, or laboratory areas) (IC) (13). 
C. Gloves 
1. Wear medical gloves when a potential 
exists for contacting blood, saliva, OPIM, or 
mucous membranes (IB, IC) (1,2,7,8,13). 
2. Wear a new pair of medical gloves for each patient, 
remove them promptly after use, and wash hands 
immediately to avoid transfer of microorganisms 
to other patients or environments (IB) (1,7,8,123). 
3. Remove gloves that are torn, cut, or 
punctured as soon as feasible and wash hands 
before regloving (IB, IC) (13,210,211). 
4. Do not wash surgeon’s or patient examination 
gloves before use or wash, disinfect, or sterilize 
gloves for reuse (IB, IC) (13,138,177,212,213). 
5. Ensure that appropriate gloves in the correct 
size are readily accessible (IC) (13). 
6. Use appropriate gloves (e.g., puncture- and 
chemical-resistant utility gloves) when 
cleaning instruments and performing 
housekeeping tasks involving contact 
with blood or OPIM (IB, IC) (7,13,15). 
7. Consult with glove manufacturers regarding 
the chemical compatibility of glove 
material and dental materials used (II). 
D. Sterile Surgeon’s Gloves and Double Gloving During Oral Surgical Procedures 
1. Wear sterile surgeon’s gloves when performing 
oral surgical procedures (IB) (2,8,137). 
2. No recommendation is offered regarding the 
effectiveness of wearing two pairs of gloves 
to prevent disease transmission during oral 
surgical procedures. The majority of studies 
among health care personnel and DHCP have 
demonstrated a lower frequency of inner glove 
perforation and visible blood on the surgeon’s 
hands when double gloves are worn; however, 
the effectiveness of wearing two pairs of 
gloves in preventing disease transmission has 
not been demonstrated (Unresolved issue).
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V. Contact Dermatitis and Latex Hypersensitivity 
A. General Recommendations 
1. Educate DHCP regarding the signs, symptoms, 
and diagnoses of skin reactions associated with 
frequent hand hygiene and glove use (IB) (5,31,32). 
2. Screen all patients for latex allergy (e.g., take 
health history and refer for medical consultation 
when latex allergy is suspected) (IB) (32). 
3. Ensure a latex-safe environment for patients 
and DHCP with latex allergy (IB) (32). 
4. Have emergency treatment kits with latex-
free products available at all times (II) (32). 
VI. Sterilization and Disinfection of Patient-Care Items 
A. General Recommendations 
1. Use only FDA-cleared medical devices for 
sterilization and follow the manufacturer’s 
instructions for correct use (IB) (248). 
2. Clean and heat-sterilize critical dental instruments 
before each use (IA) (2,137,243,244,246,249,407). 
3. Clean and heat-sterilize semicritical items 
before each use (IB) (2,249,260,407). 
4. Allow packages to dry in the sterilizer before they 
are handled to avoid contamination (IB) (247). 
5. Use of heat-stable semicritical 
alternatives is encouraged (IB) (2). 
6. Reprocess heat-sensitive critical and semi-
critical instruments by using FDA-cleared 
sterilant / high-level disinfectants or an 
FDA-cleared low-temperature sterilization 
method (e.g., ethylene oxide). Follow 
manufacturer’s instructions for use of chemical 
sterilants / high-level disinfectants (IB) (243). 
7. Single-use disposable instruments are acceptable 
alternatives if they are used only once and 
disposed of correctly (IB, IC) (243,383). 
8. Do not use liquid chemical sterilants / high-level 
disinfectants for environmental surface disinfection 
or as holding solutions (IB, IC) (243,245). 
9. Ensure that noncritical patient-care items are 
barrier-protected or cleaned, or if visibly soiled, 
cleaned and disinfected after each use with an 
EPA-registered hospital disinfectant. If visibly 
contaminated with blood, use an EPA-registered 
hospital disinfectant with a tuberculocidal 
claim (i.e., intermediate level) (IB) (2,243,244). 
10. Inform DHCP of all OSHA guidelines for exposure 
to chemical agents used for disinfection and 
sterilization. Using this report, identify areas and 
tasks that have potential for exposure (IC) (15). 
B. Instrument Processing Area 
1. Designate a central processing area. Divide 
the instrument processing area, physically or, 
at a minimum, spatially, into distinct areas for 
1) receiving, cleaning, and decontamination; 
2) preparation and packaging; 3) sterilization; 
and 4) storage. Do not store instruments in 
an area where contaminated instruments 
are held or cleaned (II) (173,247,248).  
2. Train DHCP to employ work practices that 
prevent contamination of clean areas (II). 
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C. Receiving, Cleaning, and Decontamination Work Area 
1. Minimize handling of loose contaminated 
instruments during transport to the instrument 
processing area. Use work-practice controls (e.g., 
carry instruments in a covered container) to 
minimize exposure potential (II). Clean all visible 
blood and other contamination from dental 
instruments and devices before sterilization or 
disinfection procedures (IA) (243,249 – 252). 
2. Use automated cleaning equipment (e.g., 
ultrasonic cleaner or washer-disinfector) to remove 
debris to improve cleaning effectiveness and 
decrease worker exposure to blood (IB) (2,253). 
3. Use work-practice controls that minimize contact 
with sharp instruments if manual cleaning is 
necessary (e.g., long-handled brush) (IC) (14). 
4. Wear puncture- and chemical-resistant / heavy-
duty utility gloves for instrument cleaning 
and decontamination procedures (IB) (7).
5. Wear appropriate PPE (e.g., mask, protective 
eyewear, and gown) when splashing or spraying 
is anticipated during cleaning (IC) (13). 
D. Preparation and Packaging 
1. Use an internal chemical indicator in each 
package. If the internal indicator cannot be 
seen from outside the package, also use 
an external indicator (II) (243,254,257). 
2. Use a container system or wrapping compatible 
with the type of sterilization process used and that 
has received FDA clearance (IB) (243,247,256). 
3. Before sterilization of critical and semicritical 
instruments, inspect instruments for cleanliness, 
then wrap or place them in containers designed 
to maintain sterility during storage (e.g., cassettes 
and organizing trays) (IA) (2,247,255,256). 
E. Sterilization of Unwrapped Instruments 
1. Clean and dry instruments before the 
unwrapped sterilization cycle (IB) (248). 
2. Use mechanical and chemical indicators for 
each unwrapped sterilization cycle (i.e., place an 
internal chemical indicator among the instruments 
or items to be sterilized) (IB) (243,258). 
3. Allow unwrapped instruments to dry and cool 
in the sterilizer before they are handled to avoid 
contamination and thermal injury (II) (260). 
4. Semicritical instruments that will be used 
immediately or within a short time can be 
sterilized unwrapped on a tray or in a container 
system, provided that the instruments are 
handled aseptically during removal from the 
sterilizer and transport to the point of use (II). 
5. Critical instruments intended for immediate 
reuse can be sterilized unwrapped if the 
instruments are maintained sterile during 
removal from the sterilizer and transport 
to the point of use (e.g., transported in a 
sterile covered container) (IB) (258). 
6. Do not sterilize implantable devices 
unwrapped (IB) (243,247). 
7. Do not store critical instruments 
unwrapped (IB) (248). 
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F. Sterilization Monitoring 
1. Use mechanical, chemical, and biological 
monitors according to the manufacturer’s 
instructions to ensure the effectiveness of 
the sterilization process (IB) (248,278,279). 
2. Monitor each load with mechanical (e.g., 
time, temperature, and pressure) and 
chemical indicators (II) (243,248). 
3. Place a chemical indicator on the inside of each 
package. If the internal indicator is not visible 
from the outside, also place an exterior chemical 
indicator on the package (II) (243,254,257). 
4. Place items / packages correctly and loosely 
into the sterilizer so as not to impede 
penetration of the sterilant (IB) (243). 
5. Do not use instrument packs if mechanical 
or chemical indicators indicate inadequate 
processing (IB) (243,247,248). 
6. Monitor sterilizers at least weekly by using a 
biological indicator with a matching control 
(i.e., biological indicator and control from 
same lot number) (IB) (2,9,243,247,278,279). 
7. Use a biological indicator for every sterilizer 
load that contains an implantable device. 
Verify results before using the implantable 
device, whenever possible (IB) (243,248). 
8. The following are recommended in 
the case of a positive spore test: 
a. Remove the sterilizer from service and 
review sterilization procedures (e.g., work 
practices and use of mechanical and 
chemical indicators) to determine whether 
operator error could be responsible (II) (9). 
b. Retest the sterilizer by using biological, 
mechanical, and chemical indicators 
after correcting any identified 
procedural problems (II). 
c. If the repeat spore test is negative, and 
mechanical and chemical indicators 
are within normal limits, put the 
sterilizer back in service (II) (9,243). 
9. The following are recommended if 
the repeat spore test is positive: 
a. Do not use the sterilizer until it has been 
inspected or repaired or the exact reason for the 
positive test has been determined (II) (9,243). 
b. Recall, to the extent possible, and 
reprocess all items processed since the 
last negative spore test (II) (9,243,283). 
c. Before placing the sterilizer back in service, 
rechallenge the sterilizer with biological 
indicator tests in three consecutive empty 
chamber sterilization cycles after the 
cause of the sterilizer failure has been 
determined and corrected (II) (9,243,283). 
10. Maintain sterilization records (i.e., mechanical, 
chemical, and biological) in compliance with 
state and local regulations (IB) (243). 
G. Storage Area for Sterilized Items and Clean Dental Supplies 
1. Implement practices on the basis of date- or 
event-related shelf-life for storage of wrapped, 
sterilized instruments and devices (IB) (243,284). 
2. Even for event-related packaging, at a minimum, 
place the date of sterilization, and if multiple 
sterilizers are used in the facility, the sterilizer 
used, on the outside of the packaging material 
to facilitate the retrieval of processed items in 
the event of a sterilization failure (IB) (243,247). 
3. Examine wrapped packages of sterilized 
instruments before opening them to 
ensure the barrier wrap has not been 
compromised during storage (II) (243,284). 
4. Reclean, repack, and resterilize any instrument 
package that has been compromised (II). 
5. Store sterile items and dental supplies in covered 
or closed cabinets, if possible (II) (285). 
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VII. Environmental Infection Control 
A. General Recommendations 
1. Follow the manufacturers’ instructions for correct 
use of cleaning and EPA-registered hospital 
disinfecting products (IB, IC) (243 – 245). 
2. Do not use liquid chemical sterilants / high-
level disinfectants for disinfection of 
environmental surfaces (clinical contact 
or housekeeping) (IB, IC) (243 – 245). 
3. Use PPE, as appropriate, when cleaning and 
disinfecting environmental surfaces. Such 
equipment might include gloves (e.g., puncture- 
and chemical-resistant utility), protective clothing 
(e.g., gown, jacket, or lab coat), and protective 
eyewear / face shield, and mask (IC) (13,15). 
B. Clinical Contact Surfaces 
1. Use surface barriers to protect clinical contact 
surfaces, particularly those that are difficult to 
clean (e.g., switches on dental chairs) and change 
surface barriers between patients (II) (1,2,260,288). 
2. Clean and disinfect clinical contact surfaces 
that are not barrier-protected, by using an EPA-
registered hospital disinfectant with a low- (i.e., 
HIV and HBV label claims) to intermediate-level 
(i.e., tuberculocidal claim) activity after each 
patient. Use an intermediate-level disinfectant if 
visibly contaminated with blood (IB) (2,243,244). 
C. Housekeeping Surfaces 
1. Clean housekeeping surfaces (e.g., floors, walls, 
and sinks) with a detergent and water or an EPA-
registered hospital disinfectant / detergent on a 
routine basis, depending on the nature of the 
surface and type and degree of contamination, 
and as appropriate, based on the location in the 
facility, and when visibly soiled (IB) (243,244). 
2. Clean mops and cloths after use and allow to 
dry before reuse; or use single-use, disposable 
mop heads or cloths (II) (243,244). 
3. Prepare fresh cleaning or EPA-registered 
disinfecting solutions daily and as instructed 
by the manufacturer. (II) (243,244). 
4. Clean walls, blinds, and window curtains 
in patient-care areas when they are 
visibly dusty or soiled (II) (9,244). 
D. Spills of Blood and Body Substances 
1. Clean spills of blood or OPIM and decontaminate 
surface with an EPA-registered hospital 
disinfectant with low- (i.e., HBV and HIV label 
claims) to intermediate-level (i.e., tuberculocidal 
claim) activity, depending on size of spill 
and surface porosity (IB, IC) (13,113). 
E. Carpet and Cloth Furnishings 
1. Avoid using carpeting and cloth-upholstered 
furnishings in dental operatories, laboratories, and 
instrument processing areas (II) (9,293 – 295). 
12
F. Regulated Medical Waste 
1. General Recommendations 
a. Develop a medical waste management 
program. Disposal of regulated medical 
waste must follow federal, state, and 
local regulations (IC) (13,301). 
b. Ensure that DHCP who handle and dispose 
of regulated medical waste are trained 
in appropriate handling and disposal 
methods and informed of the possible 
health and safety hazards (IC) (13). 
2. Management of Regulated Medical 
Waste in Dental Health Care Facilities 
a. Use a color-coded or labeled container that 
prevents leakage (e.g., biohazard bag) to contain 
nonsharp regulated medical waste (IC) (13). 
b. Place sharp items (e.g., needles, scalpel blades, 
orthodontic bands, broken metal instruments, 
and burs) in an appropriate sharps container 
(e.g., puncture resistant, color-coded, and 
leakproof ). Close container immediately before 
removal or replacement to prevent spillage or 
protrusion of contents during handling, storage, 
transport, or shipping (IC) (2,8,13,113,115). 
c. Pour blood, suctioned fluids or other liquid 
waste carefully into a drain connected to 
a sanitary sewer system, if local sewage 
discharge requirements are met and the 
state has declared this an acceptable 
method of disposal. Wear appropriate PPE 
while performing this task (IC) (7,9,13).
VIII. Dental Unit Waterlines, Biofilm, and Water Quality 
A. General Recommendations 
1. Use water that meets EPA regulatory standards 
for drinking water (i.e., <500 CFU / mL of 
heterotrophic water bacteria) for routine dental 
treatment output water (IB, IC) (341,342). 
2. Consult with the dental unit manufacturer for 
appropriate methods and equipment to maintain 
the recommended quality of dental water (II) (339). 
3. Follow recommendations for monitoring water 
quality provided by the manufacturer of the 
unit or waterline treatment product (II). 
4. Discharge water and air for a minimum of 20 – 30 
seconds after each patient, from any device 
connected to the dental water system that enters 
the patient’s mouth (e.g., handpieces, ultrasonic 
scalers, and air / water syringes) (II) (2,311,344). 
5. Consult with the dental unit manufacturer 
on the need for periodic maintenance of 
antiretraction mechanisms (IB) (2,311). 
B. Boil-Water Advisories 
1. The following apply while a boil-water advisory is 
in effect: 
a. Do not deliver water from the public water 
system to the patient through the dental 
operative unit, ultrasonic scaler, or other 
dental equipment that uses the public water 
system (IB, IC) (341,342,346,349,350). 
b. Do not use water from the public water 
system for dental treatment, patient rinsing, or 
handwashing (IB, IC) (341,342,346,349,350). 
c. For handwashing, use antimicrobial-containing 
products that do not require water for use 
(e.g., alcohol-based hand rubs). If hands are 
visibly contaminated, use bottled water, 
if available, and soap for handwashing or 
an antiseptic towelette (IB, IC) (13,122). 
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2. The following apply when the boil-water advisory 
is cancelled: 
a.  Follow guidance given by the local water utility 
regarding adequate flushing of waterlines. If no 
guidance is provided, flush dental waterlines 
and faucets for 1 – 5 minutes before using 
for patient care (IC) (244,346,351,352). 
b. Disinfect dental waterlines as recommended 
by the dental unit manufacturer (II).
IX. Special Considerations 
A. Dental Handpieces and Other Devices Attached to Air and Waterlines 
1. Clean and heat-sterilize handpieces and other 
intraoral instruments that can be removed from 
the air and waterlines of dental units between 
patients (IB, IC) (2,246,275,356,357,360,407). 
2. Follow the manufacturer’s instructions for 
cleaning, lubrication, and sterilization of 
handpieces and other intraoral instruments 
that can be removed from the air and 
waterlines of dental units (IB) (361 – 363). 
3. Do not surface-disinfect; use liquid chemical 
sterilants, or ethylene oxide on handpieces 
and other intraoral instruments that can 
be removed from the air and waterlines 
of dental units (IC) (2,246,250,275). 
4. Do not advise patients to close their lips 
tightly around the tip of the saliva ejector 
to evacuate oral fluids (II) (364 – 366). 
B. Dental Radiology 
1. Wear gloves when exposing radiographs and 
handling contaminated film packets. Use 
other PPE (e.g., protective eyewear, mask, and 
gown) as appropriate if spattering of blood 
or other body fluids is likely (IA, IC) (11,13). 
2. Use heat-tolerant or disposable intraoral 
devices whenever possible (e.g., film-holding 
and positioning devices). Clean and heat-
sterilize heat-tolerant devices between 
patients. At a minimum, high-level disinfect 
semicritical heat-sensitive devices, according 
to manufacturer’s instructions (IB) (243). 
3. Transport and handle exposed radiographs in 
an aseptic manner to prevent contamination 
of developing equipment (II). 
4. The following apply for digital radiography sensors: 
a. a. Use FDA-cleared barriers (IB) (243). 
b. b. Clean and heat-sterilize, or high-level 
disinfect, between patients, barrier-protected 
semicritical items. If the item cannot tolerate 
these procedures then, at a minimum, 
protect with an FDA-cleared barrier and 
clean and disinfect with an EPA-registered 
hospital disinfectant with intermediate-level 
(i.e., tuberculocidal claim) activity, between 
patients. Consult with the manufacturer for 
methods of disinfection and sterilization of 
digital radiology sensors and for protection 
of associated computer hardware (IB) (243). 
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C. Aseptic Technique for Parenteral Medications 
1. Do not administer medication from a syringe 
to multiple patients, even if the needle 
on the syringe is changed (IA) (378). 
2. Use single-dose vials for parenteral 
medications when possible (II) (376,377). 
3. Do not combine the leftover contents of 
single-use vials for later use (IA) (376,377). 
4. The following apply if multidose vials are used: 
a. Cleanse the access diaphragm with 
70% alcohol before inserting a device 
into the vial (IA) (380,381). 
b. Use a sterile device to access a multiple-
dose vial and avoid touching the access 
diaphragm. Both the needle and syringe 
used to access the multidose vial should 
be sterile. Do not reuse a syringe even if 
the needle is changed (IA) (380,381). 
c. Keep multidose vials away from the immediate 
patient treatment area to prevent inadvertent 
contamination by spray or spatter (II). 
d. Discard the multidose vial if sterility 
is compromised (IA) (380,381). 
5. Use fluid infusion and administration sets (i.e., IV 
bags, tubings and connections) for one patient 
only and dispose of appropriately (IB) (378). 
D. Single-Use (Disposable) Devices 
1. Use single-use devices for one patient only 
and dispose of them appropriately (IC) (383). 
E. Preprocedural Mouth Rinses 
1. No recommendation is offered regarding use 
of preprocedural antimicrobial mouth rinses 
to prevent clinical infections among DHCP or 
patients. Although studies have demonstrated 
that a preprocedural antimicrobial rinse (e.g., 
chlorhexidine gluconate, essential oils, or 
povidone-iodine) can reduce the level of 
oral microorganisms in aerosols and spatter 
generated during routine dental procedures and 
can decrease the number of microorganisms 
introduced in the patient’s bloodstream 
during invasive dental procedures (391 – 399), 
the scientific evidence is inconclusive that 
using these rinses prevents clinical infections 
among DHCP or patients (see discussion, 
Preprocedural Mouth Rinses) (Unresolved issue). 
F. Oral Surgical Procedures 
1. The following apply when performing 
oral surgical procedures: 
a. Perform surgical hand antisepsis by using 
an antimicrobial product (e.g., antimicrobial 
soap and water, or soap and water 
followed by alcohol-based hand scrub with 
persistent activity) before donning sterile 
surgeon’s gloves (IB) (127 – 132,137). 
b. Use sterile surgeon’s gloves 
(IB) (2,7,121,123,137). 
c. Use sterile saline or sterile water as a 
coolant / irrigant when performing oral 
surgical procedures. Use devices specifically 
designed for delivering sterile irrigating fluids 
(e.g., bulb syringe, single-use disposable 
products, and sterilizable tubing) (IB) (2,121). 
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G. Handling of Biopsy Specimens 
1. During transport, place biopsy specimens 
in a sturdy, leakproof container labeled with 
the biohazard symbol (IC) (2,13,14). 
2. If a biopsy specimen container is visibly 
contaminated, clean and disinfect the outside 
of a container or place it in an impervious bag 
labeled with the biohazard symbol (IC) (2,13). 
H. Handling of Extracted Teeth 
1. Dispose of extracted teeth as regulated medical 
waste unless returned to the patient (IC) (13,14). 
2. Do not dispose of extracted teeth 
containing amalgam in regulated medical 
waste intended for incineration (II). 
3. Clean and place extracted teeth in a leakproof 
container, labeled with a biohazard symbol, and 
maintain hydration for transport to educational 
institutions or a dental laboratory (IC) (13,14). 
4. Heat-sterilize teeth that do not contain 
amalgam before they are used for 
educational purposes (IB) (403,405,406). 
I. Dental Laboratory 
1. Use PPE when handling items received 
in the laboratory until they have been 
decontaminated (IA, IC) (2,7,11,13,113). 
2. Before they are handled in the laboratory, clean, 
disinfect, and rinse all dental prostheses and 
prosthodontic materials (e.g., impressions, bite 
registrations, occlusal rims, and extracted teeth) 
by using an EPA-registered hospital disinfectant 
having at least an intermediate-level (i.e., 
tuberculocidal claim) activity (IB) (2,249,252,407). 
3. Consult with manufacturers regarding the 
stability of specific materials (e.g., impression 
materials) relative to disinfection procedures (II). 
4. Include specific information regarding 
disinfection techniques used (e.g., solution used 
and duration), when laboratory cases are sent 
off-site and on their return (II) (2,407,409). 
5. Clean and heat-sterilize heat-tolerant items 
used in the mouth (e.g., metal impression 
trays and face-bow forks) (IB) (2,407). 
6. Follow manufacturers’ instructions for cleaning 
and sterilizing or disinfecting items that become 
contaminated but do not normally contact the 
patient (e.g., burs, polishing points, rag wheels, 
articulators, case pans, and lathes). If manufacturer 
instructions are unavailable, clean and heat-
sterilize heat-tolerant items or clean and disinfect 
with an EPA-registered hospital disinfectant 
with low- (HIV, HBV effectiveness claim) to 
intermediate-level (tuberculocidal claim) activity, 
depending on the degree of contamination (II). 
J. Laser / Electrosurgery Plumes / Surgical Smoke 
1. No recommendation is offered regarding practices 
to reduce DHCP exposure to laser plumes / surgical 
smoke when using lasers in dental practice. 
Practices to reduce DHCP exposure to laser 
plumes / surgical smoke have been suggested, 
including use of a) standard precautions (e.g., 
high-filtration surgical masks and possibly full face 
shields) (437); b) central room suction units with 
in-line filters to collect particulate matter from 
minimal plumes; and c) dedicated mechanical 
smoke exhaust systems with a high-efficiency 
filter to remove substantial amounts of laser-
plume particles. The effect of the exposure (e.g., 
disease transmission or adverse respiratory 
effects) on DHCP from dental applications 
of lasers has not been adequately evaluated 
(see previous discussion, Laser / Electrosurgery 
Plumes or Surgical Smoke) (Unresolved issue). 
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K. Mycobacterium tuberculosis 
1. General Recommendations 
a. Educate all DHCP regarding the recognition of 
signs, symptoms, and transmission of TB (IB). 
b. Conduct a baseline TST, preferably by using 
a two-step test, for all DHCP who might 
have contact with persons with suspected 
or confirmed active TB, regardless of the 
risk classification of the setting (IB). 
c. Assess each patient for a history of TB as 
well as symptoms indicative of TB and 
document on the medical history form (IB). 
d. Follow CDC recommendations for 1) developing, 
maintaining, and implementing a written 
TB infection-control plan; 2) managing 
a patient with suspected or active TB; 3) 
completing a community risk-assessment 
to guide employee TSTs and follow-up; and 
4) managing DHCP with TB disease (IB).
2. The following apply for patients known 
or suspected to have active TB: 
a. Evaluate the patient away from other patients 
and DHCP. When not being evaluated, 
the patient should wear a surgical mask 
or be instructed to cover mouth and 
nose when coughing or sneezing (IB). 
b. Defer elective dental treatment until 
the patient is noninfectious (IB). 
c. Refer patients requiring urgent dental 
treatment to a previously identified 
facility with TB engineering controls and 
a respiratory protection program (IB). 
L. Creutzfeldt-Jakob Disease (CJD) and Other Prion Diseases 
1. No recommendation is offered regarding use 
of special precautions in addition to standard 
precautions when treating known CJD or vCJD 
patients. Potential infectivity of oral tissues 
in CJD or vCJD patients is an unresolved 
issue. Scientific data indicate the risk, if any, 
of sporadic CJD transmission during dental 
and oral surgical procedures is low to nil. Until 
additional information exists regarding the 
transmissibility of CJD or vCJD during dental 
procedures, special precautions in addition to 
standard precautions might be indicated when 
treating known CJD or vCJD patients; a list of such 
precautions is provided for consideration without 
recommendation (see Creutzfeldt-Jakob Disease 
and Other Prion Diseases) (Unresolved issue). 
M. Program Evaluation 
1. Establish routine evaluation of the infection-control 
program, including evaluation of performance 
indicators, at an established frequency (II). 
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